Clinical Trial Detail

NCT ID NCT03091660
Title Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Southwest Oncology Group
Indications

bladder carcinoma in situ

transitional cell carcinoma

Therapies

BCG Tokyo-172 Strain Solution

BCG solution

Age Groups: adult child senior

No variant requirements are available.